CADE clarifies predatory pricing criteria
Credit: Stas_V/iStock
Brazil’s competition authority has recommended that its tribunal find that Genzyme did not foreclose rivals from the market to supply dialysis medication.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10